Dr. Maureen Murphy, Ira Brind Professor and program leader of the Molecular & Cellular Oncogenesis Program of The Wistar Institute Cancer Center, has been investigating the importance of inherited mutations in the gene encoding p53 tumor suppr…
PHILADELPHIA — (July 28, 2020) — The Wistar Institute and Cheyney University of Pennsylvania have launched a strategic collaboration uniting the nation’s first independent biomedical research institute and the nation’s first historically Black col…
PHILADELPHIA — (July 6, 2020) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of Chengyu Liang, M.D., Ph.D., as professor in the Molecular & Cellular …
The effects of COVID-19 have dramatically changed the way we live, learn and work. While many things have come to a standstill, Wistar research has never stopped and even new educational projects have managed to come to fruition. One shining …
Despite an unprecedented volume of research, there are still many unanswered questions on COVID-19, especially regarding the extremely varied clinical course the disease takes, ranging from asymptomatic to severe, even fatal. The evidence collecte…
PHILADELPHIA — (June 25th, 2020) — The Wistar Institute, a biomedical research leader in cancer, immunology and infectious diseases, and Allevi, Inc. a Philadelphia based startup pioneering innovative 3D biofabrication technologies, announce a col…
When I graduated from medical school, many years ago, I took an oath. An oath to preserve and uphold human life. All human life. What I saw in the horrific, excruciating minutes of the video in Minneapolis made a mockery of that oath, threw it in …
Research assistant professor Ami Patel has spent her career committed to using novel engineering approaches to fight harmful infectious diseases. Her work focuses on developing next generation vaccines and immunotherapies using DNA as pa…
PHILADELPHIA — (May. 28, 2020) — Scientists at The Wistar Institute developed a synthetic DNA approach that instructs in vivo production of a human monoclonal antibody able to neutralize hepatitis B virus (HBV) and prevent infection of liver cells…
PHILADELPHIA — (May 20, 2020) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious disease, announces a study reporting initial immunogenicity of a synthetic DNA vaccine for SARS-CoV-2 developed …
